AIM ImmunoTech Market Sentiment

SPY763.20 QQQ692.05+0.99%BTC/USD78,320.00+1.27%DIA525.16+1.57%GLD370.28+3.07%TLT81.42+0.38%

Premium Services

AIM ImmunoTech Inc

AIMAMEX

Trade with Public

$0.1607

N/A

Last update: Nov 4, 6:06 AM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Stock Report

AIM ImmunoTech Market Sentiment - Benzinga

AIM ImmunoTech Market Sentiment

Market sentiment signals for AIM ImmunoTech (AIM): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.8% short float

Options Flow— N/A

Insider Activity▲ Net Buyer (30d)

Analyst Consensus

Buy

2 analysts

Options Flow (P/C)

—

Avg Consensus PT

+2400.0%

Highest Price Target

+4275.0%

Ascendiant Capital

Lowest Price Target

+525.0%

Maxim Group

Short Interest

2.8%

Declining — Bullish

Insider Activity (30d)

Net Buyer

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 20, 2026	Ascendiant Capital	Edward Woo—	+4275.0%	$9 → $7	Maintained	Buy
Jun 1, 2026	Ascendiant Capital	Edward Woo—	+5525.0%	$10 → $9	Maintained	Buy
Apr 10, 2026	Ascendiant Capital	Edward Woo—	+6150.0%	$22 → $10	Maintained	Buy
Dec 8, 2025	Ascendiant Capital	Edward Woo—	+13637.5%	$24 → $22	Maintained	Buy
Oct 3, 2025	Ascendiant Capital	Edward Woo—	+14887.5%	$150 → $24	Maintained	Buy
Dec 10, 2024	Ascendiant Capital	Edward Woo—	+2712.5%	$5 → $5	Maintained	Buy
Oct 22, 2024	Maxim Group	Jason McCarthy—	+525.0%	$2 → $1	Maintained	Buy
Sep 3, 2024	Ascendiant Capital	Edward Woo—	+3025.0%	$5 → $5	Maintained	Buy

Insider & Market Activity News

PRO
AIM ImmunoTech Form 4 Filing Shows CEO Thomas K Equels Bought 50,000 Shares At An Average Price Of $0.13/Share

Benzinga Newsdesk

PRO
SEC Form 4 Filing Shows AIM ImmunoTech CEO And Director Thomas K. Equels Purchases 85,000 Shares At An Average Price Of $0.20

Benzinga Newsdesk

PRO
AIM ImmunoTech Form4 Filing Shows CEO And President Thomas K Equels Bought 60,110 Shares At An Average Price Of $0.18/Share

- SEC Filing

Benzinga Newsdesk

AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying

The Dow Jones index closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying

The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed lower by more than 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

AIM ImmunoTech Inc

AIM ImmunoTech Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

Insider & Market Activity News

PRO
AIM ImmunoTech Form 4 Filing Shows CEO Thomas K Equels Bought 50,000 Shares At An Average Price Of $0.13/Share

PRO
SEC Form 4 Filing Shows AIM ImmunoTech CEO And Director Thomas K. Equels Purchases 85,000 Shares At An Average Price Of $0.20

PRO
AIM ImmunoTech Form4 Filing Shows CEO And President Thomas K Equels Bought 60,110 Shares At An Average Price Of $0.18/Share

AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying

AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying

NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying

People Also Watch

Bulls vs Bears

People Also Watch

AIM ImmunoTech Inc

AIM ImmunoTech Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

Insider & Market Activity News

PROAIM ImmunoTech Form 4 Filing Shows CEO Thomas K Equels Bought 50,000 Shares At An Average Price Of $0.13/Share

PROSEC Form 4 Filing Shows AIM ImmunoTech CEO And Director Thomas K. Equels Purchases 85,000 Shares At An Average Price Of $0.20

PROAIM ImmunoTech Form4 Filing Shows CEO And President Thomas K Equels Bought 60,110 Shares At An Average Price Of $0.18/Share

AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying

AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying

NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying

People Also Watch

Bulls vs Bears

People Also Watch

PRO
AIM ImmunoTech Form 4 Filing Shows CEO Thomas K Equels Bought 50,000 Shares At An Average Price Of $0.13/Share

PRO
SEC Form 4 Filing Shows AIM ImmunoTech CEO And Director Thomas K. Equels Purchases 85,000 Shares At An Average Price Of $0.20

PRO
AIM ImmunoTech Form4 Filing Shows CEO And President Thomas K Equels Bought 60,110 Shares At An Average Price Of $0.18/Share